Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Bald-headed individuals may need early non-invasive detection for skin changes linked to cancer risk.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

3D models and organoids improve liposarcoma research and therapy development.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Keratoacanthomas and squamous cell carcinomas have similar keratin patterns, making them hard to tell apart.

Medicinal plants have potential as alternative cancer treatments due to their ability to target and kill cancer cells.

Milia may come from the outer part of the hair follicle.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Suppressing certain hormones might help prevent prostate cancer.

Orlistat might block the body's ability to absorb thyroid medication.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Finasteride does not prevent bladder cancer.

Early detection and complete surgical removal are crucial for better outcomes in treating pilomatrix carcinoma.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Some cancer treatments can cause abnormal fine hair growth.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.